Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium–glucose cotransporter 2 inhibitors
M Packer - European journal of heart failure, 2020 - Wiley Online Library
In five large‐scale trials involving> 40 000 patients, sodium–glucose cotransporter 2
(SGLT2) inhibitors decreased the risk of serious heart failure events by 25–40%. This effect …
(SGLT2) inhibitors decreased the risk of serious heart failure events by 25–40%. This effect …
[PDF][PDF] Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium–glucose cotransporter 2 inhibitors
M Packer - 2020 - scholar.archive.org
In five large-scale trials involving> 40 000 patients, sodium–glucose cotransporter 2
(SGLT2) inhibitors decreased the risk of serious heart failure events by 25–40%. This effect …
(SGLT2) inhibitors decreased the risk of serious heart failure events by 25–40%. This effect …
Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitors.
M Packer - European Journal of Heart Failure, 2020 - europepmc.org
In five large-scale trials involving> 40 000 patients, sodium-glucose cotransporter 2 (SGLT2)
inhibitors decreased the risk of serious heart failure events by 25-40%. This effect cannot be …
inhibitors decreased the risk of serious heart failure events by 25-40%. This effect cannot be …
[引用][C] Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium–glucose cotransporter 2 inhibitors
M Packer - European Journal of Heart Failure, 2020 - cir.nii.ac.jp
Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective
effect of sodium–glucose cotransporter 2 inhibitors | CiNii Research CiNii 国立情報学研究所 …
effect of sodium–glucose cotransporter 2 inhibitors | CiNii Research CiNii 国立情報学研究所 …
Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitors
M Packer - European journal of heart failure, 2020 - pubmed.ncbi.nlm.nih.gov
In five large-scale trials involving> 40 000 patients, sodium-glucose cotransporter 2 (SGLT2)
inhibitors decreased the risk of serious heart failure events by 25-40%. This effect cannot be …
inhibitors decreased the risk of serious heart failure events by 25-40%. This effect cannot be …